kittredgeihuhyla1951.blogspot.com
The company reported $92.4 million in revenue for the quarter endingApril 30, up 2 percent from the same perios last year. It earned $11 million in net income, or 33 cents per dilutefd share, during the second quarter, comparedd with $9.2 million, or 28 centss per diluted share, during the second quarter oflast year. Analysts polled by expected the companyt to earn 29 cents per shareand $89 millioh in revenue. Martek (NASDAQ: MATK) sells nutritional oils deriveds from algae that are used ininfantr formula, dietary supplements and food productx such as yogurt and juice. Sales of its nutritionaol supplements to the nursing market rose to arecord $9.
8 But the company warned that its infan t formula sales in the third and fourth quarters could drop as retaileras trim their inventories of the The company anticipates that infant formula revenue will grow in fiscal 2010 as a result of strong demans for infant formula products containingt its nutritional oils DHA and ARA. The Omega-3 fatty acides are believed to play an importanty role in brain andeye development.
study that could show that Martek’e DHA can slow the progressionof Alzheimer’s
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment